MicroRNA-203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2
出版年份 2013 全文链接
标题
MicroRNA-203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2
作者
关键词
-
出版物
Molecular Medicine Reports
Volume 9, Issue 2, Pages 503-508
出版商
Spandidos Publications
发表日期
2013-11-20
DOI
10.3892/mmr.2013.1814
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Long and Short of MicroRNA
- (2013) Luke A. Yates et al. CELL
- Development of Dual PLD1/2 and PLD2 Selective Inhibitors from a Common 1,3,8-Triazaspiro[4.5]decane Core: Discovery of ML298 and ML299 That Decrease Invasive Migration in U87-MG Glioblastoma Cells
- (2013) Matthew C. O’Reilly et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expression level of human miR-34a correlates with glioma grade and prognosis
- (2013) Haifeng Gao et al. JOURNAL OF NEURO-ONCOLOGY
- MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma
- (2013) Jianguo He et al. JOURNAL OF SURGICAL ONCOLOGY
- Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor
- (2013) Zhanwen He et al. MEDICAL ONCOLOGY
- MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells
- (2013) S. B. Rani et al. NEURO-ONCOLOGY
- Overexpression of phospholipase D enhances Bcl-2 expression by activating STAT3 through independent activation of ERK and p38MAPK in HeLa cells
- (2012) Hye-Jin Choi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- miR-203 inhibits proliferation of HCC cells by targeting survivin
- (2012) Wang Wei et al. CELL BIOCHEMISTRY AND FUNCTION
- Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy
- (2012) Alexandra Nikaki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin
- (2012) Ka Bian et al. FEBS LETTERS
- miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1
- (2012) NOBUYOSHI TAKESHITA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 Protein in Human Melanoma Cells
- (2012) Shunsuke Noguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
- (2012) Chen Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Biochemical and cellular implications of a dual lipase-GEF function of phospholipase D2 (PLD2)
- (2012) J. Gomez-Cambronero JOURNAL OF LEUKOCYTE BIOLOGY
- MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma
- (2012) K Boll et al. ONCOGENE
- miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression
- (2012) Vanessa Abella et al. PLoS One
- MicroRNA-203 inhibits cell proliferation by repressing ΔNp63 expression in human esophageal squamous cell carcinoma
- (2011) Yang Yuan et al. BMC CANCER
- Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium
- (2010) Melissa L. Bondy et al. CANCER
- Epidermal growth factor increases lysophosphatidic acid production in human ovarian cancer cells: roles for phospholipase D2 and receptor transactivation
- (2009) Ashley J. Snider et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma
- (2009) Mayuko Furuta et al. CARCINOGENESIS
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
- (2008) Aaron J. Schetter et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started